000 01484 a2200445 4500
005 20250517152550.0
264 0 _c20180326
008 201803s 0 0 eng d
022 _a1432-2072
024 7 _a10.1007/s00213-017-4634-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSakurai, Hitoshi
245 0 0 _aPredicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data.
_h[electronic resource]
260 _bPsychopharmacology
_cAug 2017
300 _a2453-2461 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAntidepressive Agents
_xtherapeutic use
650 0 4 _aCitalopram
_xtherapeutic use
650 0 4 _aDepressive Disorder, Major
_xdiagnosis
650 0 4 _aDisorders of Excessive Somnolence
_xdiagnosis
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOutpatients
650 0 4 _aPrognosis
650 0 4 _aPsychiatric Status Rating Scales
650 0 4 _aPsychomotor Agitation
_xdiagnosis
650 0 4 _aRecurrence
650 0 4 _aRisk Factors
650 0 4 _aSelf Report
650 0 4 _aTreatment Outcome
700 1 _aSuzuki, Takefumi
700 1 _aYoshimura, Kimio
700 1 _aMimura, Masaru
700 1 _aUchida, Hiroyuki
773 0 _tPsychopharmacology
_gvol. 234
_gno. 16
_gp. 2453-2461
856 4 0 _uhttps://doi.org/10.1007/s00213-017-4634-5
_zAvailable from publisher's website
999 _c27140197
_d27140197